Abstract Topics

**Authors submitting ongoing trial abstracts for clinical trials that will complete in time to release results in a late-breaking session, should submit their abstract through the designated system for Ongoing Trails only. Please note: There are two separate systems, one for ongoing trails only and one for the regular abstract submission.

 

01.ONGOING TRIALS **

02.CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – NEITHER THROMBOLYSIS NOR THROMBECTOMY

03.CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – THROMBOLYSIS OR THROMBECTOMY

04.CLINICAL TRIAL RESULTS – PREVENTION

05.CLINICAL TRIAL RESULTS – REHABILITATION & RECOVERY

06.THROMBOLYSIS – EXCLUDING CLINICAL TRIAL RESULTS

07.HYPERACUTE MANAGEMENT – EXCLUDING CLINICAL TRIAL RESULTS

08.NEUROINTERVENTION – EXCLUDING CLINICAL TRIAL RESULTS

09.REHABILITATION AND RECOVERY – EXCLUDING CLINICAL TRIAL RESULTS

09.PREVENTION – EXCLUDING CLINICAL TRIAL RESULTS

10.IMAGING – HYPERACUTE

11.IMAGING – NON ACUTE INCLUDING NEUROSONOLOGY

12.SERVICE ORGANISATION

13.NURSING, ALLIED HEALTH PROFESSIONALS AND CARERS

14.DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY

15.EPIDEMIOLOGY OF STROKE

16.PROGNOSIS AND OUTCOME AFTER STROKE

17.PATHOPHYSIOLOGY OF STROKE

18.RISK FACTORS FOR STROKE

19.RARE CAUSES, STROKE IN THE YOUNG

20.INTRACEREBRAL HEMORRHAGE

21.ATRIAL FIBRILLATION, CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS

22.COGNITION AND VASCULAR COGNITIVE IMPAIRMENT

23.SMALL VESSEL DISEASE

14.SAH, ANEURYSMS AND VASCULAR MALFORMATIONS

25.APHASIA, NEGLECT AND OTHER CORTICAL DEFICITS

26.WOMEN AND STROKE

27.YOUNG STROKE PHYSICIANS AND RESEARCHERS: RESEARCH DESIGN WORKSHOP FOR STUDIES IN DEVELOPMENT *

28.EXPERIMENTAL/TRANSLATIONAL MEDICINE

29.GENETICS, 'OMICS AND BIOMARKERS

30. SYSTEMATIC REVIEW AND META-ANALYSIS

31.CASE REPORTS

 

* ​Young investigators (<35 years) are invited to submit an abstract describing a planned research study or an ongoing project still under development, in either clinical or basic science, for an ESO-Young Stroke Physicians and Researchers ​workshop. After each successful applicant's oral presentation, a senior, internationally-renowned investigator will provide a constructive assessment of the study's design and advise on its future development, before opening the proposal up for discussion. In addition to providing expert guidance to develop your study, the workshop will also provide the o​pportunity to establish collaborations and promote your work to the wider community.

** Ongoing trials will be accepted for poster presentation only. ​

Keep Me Updated